The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer-Reference-Cited by-同舟云学术

The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer

Published:2020-11 Issue:4 Volume:47 Page:457-467
ISSN:0094-0143
Container-title:Urologic Clinics of North America
language:en
Short-container-title:Urologic Clinics of North America

Author:

Bilusic Marijo,Einstein David J.,Karzai Fatima H.,Dahut William L.,Gulley James L.,Aragon-Ching Jeanny B.,Madan Ravi A.

Publisher

Elsevier BV

Subject

Urology

Reference64 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results;Roehl;J Urol,2004

3. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy;Freedland;JAMA,2005

4. Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality;Freedland;J Clin Oncol,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients;Current Opinion in Oncology;2024-02-23

2. Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer;Cancer Treatment Reviews;2024-01

3. Long non-coding RNA ENST00000503625 is a potential prognostic biomarker and metastasis suppressor gene in prostate cancer;Journal of Cancer Research and Clinical Oncology;2023-03-15

4. First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC);Journal for ImmunoTherapy of Cancer;2023-03

5. A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic Immunotherapy;Advanced Functional Materials;2023-01-25